Oppenheimer: Solid Topline Performance And Multiple, But Comp Expense Caps Profit Growth
AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.
Zentalis Pharmaceuticals executive sells shares worth $4,475
Vincent Vultaggio, the PAO and Interim PFO of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently sold shares of the company, according to a recent SEC filing. The transaction comes as the ...